SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 75 filers reported holding SAVARA INC in Q1 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $406,103 | +139.1% | 100,770 | +195.5% | 0.00% | – |
| Q1 2024 | $169,818 | +60.5% | 34,100 | +51.5% | 0.00% | – |
| Q4 2023 | $105,797 | +47.3% | 22,510 | +18.5% | 0.00% | – |
| Q3 2023 | $71,820 | +88.3% | 19,000 | +59.1% | 0.00% | – |
| Q2 2023 | $38,148 | -59.0% | 11,940 | -73.4% | 0.00% | – |
| Q1 2021 | $93,000 | +78.8% | 44,900 | 0.0% | 0.00% | – |
| Q4 2020 | $52,000 | +2.0% | 44,900 | -3.4% | 0.00% | – |
| Q3 2020 | $51,000 | -64.3% | 46,500 | -19.1% | 0.00% | – |
| Q2 2020 | $143,000 | +33.6% | 57,500 | +13.6% | 0.00% | – |
| Q1 2020 | $107,000 | -48.6% | 50,600 | +8.8% | 0.00% | – |
| Q4 2019 | $208,000 | +69.1% | 46,500 | 0.0% | 0.00% | – |
| Q3 2019 | $123,000 | +11.8% | 46,500 | 0.0% | 0.00% | – |
| Q2 2019 | $110,000 | -28.1% | 46,500 | +123.6% | 0.00% | – |
| Q1 2019 | $153,000 | +51.5% | 20,800 | +55.2% | 0.00% | – |
| Q4 2018 | $101,000 | -14.4% | 13,400 | +26.4% | 0.00% | – |
| Q3 2018 | $118,000 | – | 10,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,896,551 | $9,034,000 | 11.23% |
| Bain Capital Life Sciences Investors, LLC | 11,622,598 | $15,226,000 | 1.48% |
| NEA Management Company, LLC | 24,137,931 | $31,621,000 | 0.91% |
| VR Adviser, LLC | 1,905,265 | $2,496,000 | 0.40% |
| Sio Capital Management, LLC | 716,262 | $938,000 | 0.31% |
| Ikarian Capital, LLC | 1,622,552 | $2,126,000 | 0.28% |
| FARALLON CAPITAL MANAGEMENT LLC | 8,505,403 | $11,142,000 | 0.05% |
| Marquette Asset Management, LLC | 93,246 | $122,000 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6,864,551 | $8,993,000 | 0.02% |
| AXA S.A. | 6,955,664 | $9,111,960 | 0.01% |